Paper41301412
Cisplatin-Induced Skeletal Muscle Atrophy: Biomolecular Mechanisms and the Protective Role of Exercise-Induced Myokines.
Xu M and 1 other. Biomolecules, 2025. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Cisplatin-Induced Skeletal Muscle Atrophy: Biomolecular Mechanisms and the Protective Role of Exercise-Induced Myokines. Papers, record 41301412. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41301412
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Cisplatin-Induced Skeletal Muscle Atrophy: Biomolecular Mechanisms and the Protective Role of Exercise-Induced Myokines.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Muscular Atrophy | Major topic |
| Cisplatin | Major topic |
| Muscle, Skeletal | Major topic |
| Exercise | Major topic |
| Antineoplastic Agents | Major topic |
| Humans | |
| Animals | |
| Cytokines | |
| Oxidative Stress | |
| Myokines |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 32300964 | National Natural Science Foundation of China | PubMed |
Source PubMed
References237
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 40604168 | Skeletal muscle proteomics: considerations and opportunities. | NPJ Metab Health Dis | 2025 | https://conductscience.org/library/papers/40604168 | PubMed |
| 2 | 40194715 | Physical activity guidelines in oncology: A systematic review of the current recommendations. | Crit Rev Oncol Hematol | 2025 | https://conductscience.org/library/papers/40194715 | PubMed |
| 3 | 37554301 | Mitochondrial DNA-targeted therapy: A novel approach to combat cancer. | Cell Insight | 2023 | https://conductscience.org/library/papers/37554301 | PubMed |
| 4 | 40759570 | Cancer therapy and cachexia. | J Clin Invest | 2025 | https://conductscience.org/library/papers/40759570 | PubMed |
| 5 | 40529358 | Resistance training alleviates muscle atrophy and muscle dysfunction by reducing inflammation and regulating compromised autophagy in aged skeletal muscle. | Front Immunol | 2025 | https://conductscience.org/library/papers/40529358 | PubMed |
| 6 | 39179024 | Combination of transcriptomics and proteomics for analyzing potential biomarker and molecular mechanism underlying skeletal muscle atrophy. | J Proteomics | 2024 | https://conductscience.org/library/papers/39179024 | PubMed |
| 7 | 39456138 | Myokines May Be the Answer to the Beneficial Immunomodulation of Tailored Exercise-A Narrative Review. | Biomolecules | 2024 | https://conductscience.org/library/papers/39456138 | PubMed |
| 8 | 38155343 | A muscle exercise research revolution powered by -omics at single cell and nucleus resolution. | BMC Biol | 2023 | https://conductscience.org/library/papers/38155343 | PubMed |
| 9 | 35301821 | The association between skeletal muscle measures and chemotherapy-induced toxicity in non-small cell lung cancer patients. | J Cachexia Sarcopenia Muscle | 2022 | https://conductscience.org/library/papers/35301821 | PubMed |
| 10 | 34756760 | Loss of skeletal muscle density during neoadjuvant chemotherapy in older women with advanced stage ovarian cancer is associated with postoperative complications. | Eur J Surg Oncol | 2022 | https://conductscience.org/library/papers/34756760 | PubMed |
| 11 | 37414459 | Resistance training prescription for muscle strength and hypertrophy in healthy adults: a systematic review and Bayesian network meta-analysis. | Br J Sports Med | 2023 | https://conductscience.org/library/papers/37414459 | PubMed |
| 12 | 38352137 | Exercise intervention for the management of chemotherapy-induced peripheral neuropathy: a systematic review and network meta-analysis. | Front Neurol | 2024 | https://conductscience.org/library/papers/38352137 | PubMed |
| 13 | 37435785 | Explainable machine learning model for predicting skeletal muscle loss during surgery and adjuvant chemotherapy in ovarian cancer. | J Cachexia Sarcopenia Muscle | 2023 | https://conductscience.org/library/papers/37435785 | PubMed |
| 14 | 39682137 | Technological Resources for Physical Rehabilitation in Cancer Patients Undergoing Chemotherapy: A Scoping Review. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/39682137 | PubMed |
| 15 | 40480230 | AKT-mediated phosphorylation of TSC2 controls stimulus- and tissue-specific mTORC1 signaling and organ growth. | Dev Cell | 2025 | https://conductscience.org/library/papers/40480230 | PubMed |
| 16 | 40279258 | Decorin the antifibrotic proteoglycan and its progression in therapy. | Am J Physiol Cell Physiol | 2025 | https://conductscience.org/library/papers/40279258 | PubMed |
| 17 | 40512179 | Resistance exercise and skeletal muscle: protein synthesis, degradation, and controversies. | Eur J Appl Physiol | 2025 | https://conductscience.org/library/papers/40512179 | PubMed |
| 18 | 40358602 | Musclin Counteracts Skeletal Muscle Dysfunction and Exercise Intolerance in Heart Failure With Preserved Ejection Fraction. | Circ Heart Fail | 2025 | https://conductscience.org/library/papers/40358602 | PubMed |
| 19 | 33535507 | Effects of Exercise in Patients Undergoing Chemotherapy for Head and Neck Cancer: A Pilot Randomized Controlled Trial. | Int J Environ Res Public Health | 2021 | https://conductscience.org/library/papers/33535507 | PubMed |
| 20 | 38992214 | OBSERVE: guidelines for the refinement of rodent cancer models. | Nat Protoc | 2024 | https://conductscience.org/library/papers/38992214 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42939790 | IL-15 Signaling Pathways in the Kidney: Established Mechanisms and Hypotheses for Exercise-Associated Stress. | Biomolecules | 2026 | https://conductscience.org/library/papers/42939790 | PubMed |
| 42511007 | The 5% Problem: How the Biomedical Community Responded to the Animal-to-Human Translation Crisis, and the Case for Non-Animal Methods. | Animals (Basel) | 2026 | https://conductscience.org/library/papers/42511007 | PubMed |
| 42373827 | Zinc-polydopamine nanozyme promotes mitochondrial biogenesis and alleviates inflammation and muscle atrophy during the perioperative period of surgery. | J Mater Sci Mater Med | 2026 | https://conductscience.org/library/papers/42373827 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| FNDC5 | 252995 | PubTator's text mining | https://conductscience.org/library/genes/252995 | NCBI Gene |
| IL6 | 3569 | PubTator's text mining | https://conductscience.org/library/genes/3569 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41301412
GET https://conductscience.org/api/papers/v1/41301412/references?page=2